Divo, Miguel J.
DePietro, Michael R.
Horton, John R.
Maguire, Cherie A.
Celli, Bartolome R.
Article History
Received: 2 August 2019
Accepted: 8 January 2020
First Online: 20 January 2020
Ethics approval and consent to participate
: The study was approved by the local ethics review committee (Additional file InternalRef removed: Table S1) and conducted in accordance with the Declaration of Helsinki; all patients provided written informed consent.
: Not applicable.
: BRC reports personal fees and other from AstraZeneca and Menarini; personal fees from GlaxoSmithKline, Boehringer Ingelheim, Novartis, and Sanofi Aventis, outside the submitted work. MRDP was an employee of AstraZeneca at the time of this work and is currently an employee of Teva Pharmaceuticals. JRH was a contractor for AstraZeneca at the time of this work. MJD and CAM declare that they have no competing interests.